NCT01820130WithdrawnNot Applicable
Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure
Conditions
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Withdrawn
- Sponsor
- Abbott Medical Devices
- Locations
- 1
- Primary Endpoint
- Efficacy Marker of patient symptom via 6 Minutes Hall Walk distance for patient with advanced HF
Study Overview
Brief Summary
The purpose of this clinical investigation is to evaluate the safety and efficacy of Spinal Cord Stimulation (SCS) in advanced heart failure (HF) patients with Implantable Cardioverter Defibrillator (ICD) but not indicated for Cardiac Resynchronization Therapy (CRT).
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients has a Left Ventricular Ejection Fraction (LVEF) less than or equal to 35%
- •Patient is in New York Heart Association (NYHA) Class III
- •Patient has a QRS duration <120 ms (non-paced QRS, at the time of device Implant or protocol inclusion)
- •Patient has had an ICD implanted for >90 days
- •Patient is receiving stable and optimal medical therapy for HF (>90 days) as describe by "European Society of Cardiology 2012 recommendation for diagnosis and treatment of acute and chronic Heart Failure", except in case of contraindication or allergy
- •Patient is able to provide written Informed Consent prior to any investigational related procedure
Exclusion Criteria
- •Patient currently has an implanted spinal cord stimulator or previously had an implanted spinal cord stimulator which is now explanted or has had previous spinal surgery that would interfere with implant of percutaneous SCS leads in the upper thoracic region
- •Patient has polyneuropathy
- •Patient requires short-wave diathermy, microwave diathermy or therapeutic ultrasound diathermy
- •Patient is in NYHA class IV
- •Patient has received a tissue / organ transplant or is expected to have a tissue / organ transplant within the next 180 days
- •Patient has a cardiac resynchronization therapy (CRT) device, or LV Assist device or is expected to receive CRT, or left ventricular assist device (LVAD) within the next 180 days
- •Patient has critical valvular heart disease that requires valve repair or replacement
- •Patient has had a myocardial infarction (MI) or cardiac revascularization procedure (percutaneous coronary intervention or coronary artery bypass graft) within 90 days of enrollment
- •Patient is on IV inotropic therapy
- •Patient has active myocarditis or early postpartum cardiomyopathy
- •Patient has taken any of the following drugs within 30 days of enrollment: systemic corticosteroids, cytostatic and immunosuppressive drug therapy (cyclophosphamide, methotrexate, cyclosporine, azathioprine, etc.), DNA depleting or cytotoxic drugs
- •Patient is pregnant, or of childbearing potential and is not using adequate contraceptive methods, or nursing
- •Patient with a bleeding tendency (INR >1.2 and platelet count <100 x109 per liter)
- •Patient has a local infection at the ICD implant location or systemic infection
- •Patient has renal insufficiency (creatinine >3.0 mg/dl)
- •Patient with risk of allergy to SCS device component materials
- •Patient having one of the following condition must be considered as non relevant for SCS implantation:
- •/ Patient with active stent
- •/ Patient having bare metal stent for less than 6 months
- •/ Patient presented with an acute coronary syndrome within the last 6 months
- •/ Patient with stent on the common
- •/ Patient with a history of stent thrombosis
- •/ Coronary Patient receiving double antiplatelet medication
- •Patient is participating in another clinical study with an active treatment arm
- •Patient is less than 18 years old
- •Patient's life's expectancy is less than 1 year as assessed by investigators
Arms & Interventions
Spinal Cord Stimulation system therapy
Experimental
St Jude Medical EON mini rechargeable system
Intervention: St Jude Medical EON mini rechargeable system (Device)
Outcomes
Primary Outcomes
Efficacy Marker of patient symptom via 6 Minutes Hall Walk distance for patient with advanced HF
Time Frame: baseline to 6 months
Evaluation of 6 Minutes Hall walk (6MHW) as marker of patient symptom between baseline and after 6 months of SCS therapy.
Efficacy Marker of Cardiac remodeling via Left Ventricular End Diastolic Volume (LVEDV) of Patient with advanced HF
Time Frame: baseline and 6 Months
Evaluation of left ventricular end diastolic volume (LVEDV) as measured by cardiac echo between baseline and after 6 months of SCS therapy.
Efficacy Marker of patient symptom via NYHA class for patient with advanced HF
Time Frame: Baseline and 6 months
Evaluation of NYHA class as marker of patient symptom between baseline and after 6 months of SCS therapy.
Secondary Outcomes
- Additional efficacy markers of SCS therapy on cardiac function via echocardiography(baseline and 6 months)
- Safety composite marker of SCS therapy for patient with HF and ICD device(baseline and 6 months)
- Additional efficacy markers of SCS therapy on patient symptom via Maximal exercise test tolerance(baseline and 6 months)
- Additional efficacy markers of SCS therapy on patient symptom via Quality Of Life questionnaire(baseline to 6 months)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Neuromodulation With Spinal Stimulation MethodsSpinal Cord InjuriesSpinal Cord Injury at C5-C7 LevelParaplegia, SpinalParaplegia, IncompleteNCT06272279University of Manitoba24
Active, not recruiting
Not Applicable
Brain Controlled Spinal Cord Stimulation In Participants With Spinal Cord Injury For Lower Limb RehabilitationParaplegiaSpinal Cord InjuriesNCT06243952Ecole Polytechnique Fédérale de Lausanne3
Completed
Not Applicable
Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical StudySpinal Cord Injuries (Complete and Incomplete)Neurogenic BladderStrokeMultiple SclerosisNCT05301335SpineX Inc.126
Terminated
Not Applicable
SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) StudyFailed Back Surgery SyndromeLow Back PainPost-Laminectomy SyndromeNCT01990287Abbott Medical Devices38
Unknown
Phase 4
Management of Chronic Pain in Military Patients With Injuries Sustained During Active DutyExtremity InjuryNCT01616342Sceptor Pain Foundation180